TY - JOUR AU - Siegel, R. AU - Ward, E. AU - Brawley, O. AU - Jemal, A. PY - 2011 DA - 2011// TI - Cancer statistics: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths JO - CA Cancer J Clin VL - 61 UR - https://doi.org/10.3322/caac.20121 DO - 10.3322/caac.20121 ID - Siegel2011 ER - TY - JOUR AU - Jemal, A. AU - Bray, F. AU - Center, M. M. AU - Ferlay, J. AU - Ward, E. AU - Forman, D. PY - 2011 DA - 2011// TI - Global cancer statistics JO - CA Cancer J Clin VL - 6 UR - https://doi.org/10.3322/caac.20107 DO - 10.3322/caac.20107 ID - Jemal2011 ER - TY - JOUR AU - Chetrit, A. AU - Hirsh-Yechezkel, G. AU - Ben-David, Y. AU - Lubin, F. AU - Friedman, E. AU - Sadetzki, S. PY - 2008 DA - 2008// TI - Effect of BRCA1/2 mutations on long term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.6905 DO - 10.1200/JCO.2007.11.6905 ID - Chetrit2008 ER - TY - JOUR AU - Bast, R. C. AU - Hennessy, B. AU - Mills, G. B. PY - 2009 DA - 2009// TI - The biology of ovarian cancer: new opportunities for translation JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2644 DO - 10.1038/nrc2644 ID - Bast2009 ER - TY - JOUR AU - Badgwell, D. AU - Bast, R. C. PY - 2007 DA - 2007// TI - Early detection of ovarian cancer JO - Dis Markers VL - 23 UR - https://doi.org/10.1155/2007/309382 DO - 10.1155/2007/309382 ID - Badgwell2007 ER - TY - JOUR AU - Hamed, E. O. AU - Ahmed, H. AU - Sedeek, O. B. AU - Mohammed, A. M. AU - Abd-Alla, A. A. AU - Abdel Ghaffar, H. M. PY - 2013 DA - 2013// TI - Significance of HE4 estimation in comparison with CA 125 in diagnosis of ovarian cancer and assessment of treatment response JO - Diagn Pathol VL - 8 UR - https://doi.org/10.1186/1746-1596-8-11 DO - 10.1186/1746-1596-8-11 ID - Hamed2013 ER - TY - JOUR AU - Moore, R. G. AU - Miller, M. C. AU - Steinhoff, M. M. AU - Skates, S. J. AU - Lu, K. H. AU - Lambert-Messerlian, G. PY - 2012 DA - 2012// TI - Serum HE4 levels are less frequently elevated than CA 125 in women with benign gynecologic disorders JO - Am J Obstet Gynecol VL - 206 UR - https://doi.org/10.1016/j.ajog.2011.12.029 DO - 10.1016/j.ajog.2011.12.029 ID - Moore2012 ER - TY - JOUR AU - Azzam, A. Z. AU - Hashad, D. I. AU - Kamel, N. A. PY - 2013 DA - 2013// TI - Evaluation of HE4 as an extra biomarker to CA 125 to improve detection of ovarian carcinoma: is it time for a step forward? JO - Arch Gynecol Obstet VL - 288 UR - https://doi.org/10.1007/s00404-013-2722-2 DO - 10.1007/s00404-013-2722-2 ID - Azzam2013 ER - TY - JOUR AU - Moore, R. G. AU - Brown, A. K. AU - Miller, M. C. AU - Skates, S. AU - Allard, W. J. AU - Verch, T. PY - 2008 DA - 2008// TI - The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass JO - Gynecol Oncol VL - 108 UR - https://doi.org/10.1016/j.ygyno.2007.10.017 DO - 10.1016/j.ygyno.2007.10.017 ID - Moore2008 ER - TY - JOUR AU - Ławicki, S. AU - Gacuta-Szumarska, E. AU - Będkowska, G. E. AU - Szmitkowski, M. PY - 2012 DA - 2012// TI - Hematopoietic cytokines as tumor markers in gynecological malignancies. A multivariate analysis in epithelial ovarian cancer patients JO - Growth Factors VL - 30 UR - https://doi.org/10.3109/08977194.2012.724407 DO - 10.3109/08977194.2012.724407 ID - Ławicki2012 ER - TY - JOUR AU - Moghaddam, M. S. AU - Amini, A. AU - Morris, D. L. AU - Pourgholami, M. H. PY - 2012 DA - 2012// TI - Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer JO - Cancer Metastasis Rev VL - 31 UR - https://doi.org/10.1007/s10555-011-9337-5 DO - 10.1007/s10555-011-9337-5 ID - Moghaddam2012 ER - TY - JOUR AU - Liu, C. Z. AU - Zhang, L. AU - Chang, X. H. AU - Cheng, Y. X. AU - Cheng, H. Y. AU - Ye, X. PY - 2012 DA - 2012// TI - Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer JO - Chin J Cancer Res VL - 24 UR - https://doi.org/10.1007/s11670-012-0130-y DO - 10.1007/s11670-012-0130-y ID - Liu2012 ER - TY - JOUR AU - Kamińska, J. AU - Kowalska, M. AU - Kotowicz, B. AU - Fuksiewicz, M. PY - 2006 DA - 2006// TI - The prognostic value of cytokine levels in patients with cancer JO - Wspol Onkol VL - 10 ID - Kamińska2006 ER - TY - JOUR AU - Schummer, M. AU - Drescher, C. AU - Forrest, R. AU - Gough, S. AU - Thorpe, J. AU - Hellstrom, I. PY - 2012 DA - 2012// TI - Evaluation of ovarian cancer remission markers HE4, MMP7 and mesothelin by comparison to the established marker CA125 JO - Gynecol Oncol VL - 125 UR - https://doi.org/10.1016/j.ygyno.2011.11.050 DO - 10.1016/j.ygyno.2011.11.050 ID - Schummer2012 ER - TY - JOUR AU - Gersthein, E. S. AU - Kushlinsky, D. N. AU - Levkina, N. V. AU - Tereshkina, I. V. AU - Nosov, V. B. AU - Laktionov, K. P. PY - 2011 DA - 2011// TI - Relationship between the expression of VEGF signal components and matrix metalloproteinases in ovarian tumors JO - Bull Exp Biol Med VL - 151 UR - https://doi.org/10.1007/s10517-011-1353-5 DO - 10.1007/s10517-011-1353-5 ID - Gersthein2011 ER - TY - JOUR AU - Mahner, S. AU - Woelber, L. AU - Eulenburg, C. AU - Schwarz, J. AU - Carney, W. AU - Jaenicke, F. PY - 2010 DA - 2010// TI - TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients JO - BMC Cancer VL - 10 UR - https://doi.org/10.1186/1471-2407-10-139 DO - 10.1186/1471-2407-10-139 ID - Mahner2010 ER - TY - JOUR AU - Anderson, G. L. AU - McInthos, M. AU - Wu, L. AU - Goodman, G. AU - Thorpe, J. D. AU - Bergan, L. PY - 2010 DA - 2010// TI - Assessing lead time of selected ovarian cancer biomarkers: a nested case–control study JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djp438 DO - 10.1093/jnci/djp438 ID - Anderson2010 ER - TY - JOUR AU - Lin, Y. W. AU - Lin, C. Y. AU - Lai, H. C. AU - Chiou, J. Y. AU - Chang, C. C. AU - Yu, M. H. PY - 2006 DA - 2006// TI - Plasma proteomic pattern as biomarkers for ovarian cancer JO - Int J Gynecol Cancer. VL - 16 UR - https://doi.org/10.1111/j.1525-1438.2006.00475.x DO - 10.1111/j.1525-1438.2006.00475.x ID - Lin2006 ER - TY - JOUR AU - Chechlińska, M. PY - 2003 DA - 2003// TI - The role of cytokines in carcinogenesis JO - J Oncol VL - 53 ID - Chechlińska2003 ER - TY - JOUR AU - Jasonni, V. M. AU - Amadori, A. AU - Gentile, G. AU - Alesi, L. PY - 1999 DA - 1999// TI - Potential role of growth factorsin ovarian cancer JO - Front Biosci VL - 1 ID - Jasonni1999 ER - TY - JOUR AU - Morandi, A. AU - Barbetti, V. AU - Riverso, M. AU - DelloSbarba, P. AU - Rovida, E. PY - 2011 DA - 2011// TI - The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines JO - PLoS One VL - 6 UR - https://doi.org/10.1371/journal.pone.0027450 DO - 10.1371/journal.pone.0027450 ID - Morandi2011 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, G. E. AU - Wojtukiewicz, M. AU - Szmitkowski, M. PY - 2013 DA - 2013// TI - Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients JO - Adv Med Sci VL - 58 UR - https://doi.org/10.2478/ams-2013-0023 DO - 10.2478/ams-2013-0023 ID - Ławicki2013 ER - TY - JOUR AU - Toy, E. P. AU - Bonafé, N. AU - Savlu, A. AU - Zeiss, C. AU - Zheng, W. AU - Flick, M. PY - 2005 DA - 2005// TI - Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis JO - Clin Exp Metastasis VL - 22 UR - https://doi.org/10.1007/s10585-005-0718-4 DO - 10.1007/s10585-005-0718-4 ID - Toy2005 ER - TY - JOUR AU - Bahar, B. AU - Cayci, B. AU - Coskun, U. AU - Buyukberber, S. AU - Benekli, M. AU - Yildiz, R. PY - 2010 DA - 2010// TI - Granulocyte colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) as potential tumor markers in non-small cell lung cancer diagnosis JO - Asian Pacific J Cancer Prev VL - 11 ID - Bahar2010 ER - TY - JOUR AU - Kamińska, J. AU - Kowalska, M. AU - Kotowicz, B. PY - 2006 DA - 2006// TI - Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis JO - Oncology VL - 70 UR - https://doi.org/10.1159/000093002 DO - 10.1159/000093002 ID - Kamińska2006 ER - TY - JOUR AU - Vasiliades, G. AU - Kopanakis, N. AU - Vasiloglou, M. AU - Zografos, G. AU - Margaris, H. AU - Masselou, K. PY - 2012 DA - 2012// TI - Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer JO - Int J Biol Markers VL - 27 UR - https://doi.org/10.5301/JBM.2012.9348 DO - 10.5301/JBM.2012.9348 ID - Vasiliades2012 ER - TY - JOUR AU - Baiocchi, G. AU - Kavanagh, J. J. AU - Talpaz, M. AU - Wharton, J. T. AU - Gutterman, J. U. AU - Kurzrock, R. PY - 1991 DA - 1991// TI - Expression of the macrophage colony-stimulating factor and its receptor in gynecologic malignancies JO - Cancer VL - 67 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Baiocchi1991 ER - TY - JOUR AU - Kirma, N. AU - Hammes, L. S. AU - Liu, Y. G. AU - Nair, H. B. AU - Valente, P. T. AU - Kumar, S. PY - 2007 DA - 2007// TI - Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-06-1991 DO - 10.1158/0008-5472.CAN-06-1991 ID - Kirma2007 ER - TY - JOUR AU - Suzuki, M. AU - Ohwada, M. AU - Aida, I. AU - Tamada, T. AU - Hanamura, T. AU - Nagatomo, M. PY - 1993 DA - 1993// TI - Macrophage colony – stimulating factor as a tumor marker for epithelial ovarian cancer JO - Obstet Gynecol VL - 82 ID - Suzuki1993 ER - TY - JOUR AU - Chambers, S. K. AU - Kacinski, B. M. AU - Ivins, C. M. AU - Carcangiu, M. L. PY - 1997 DA - 1997// TI - Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1 JO - Clin Cancer Res VL - 3 ID - Chambers1997 ER - TY - JOUR AU - Haaften-Day, C. AU - Yu, S. AU - Fengji, X. AU - Yinhua, Y. AU - Berchuck, A. AU - Havrilesky, L. J. PY - 2001 DA - 2001// TI - OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma JO - Cancer VL - 92 UR - https://doi.org/3.0.CO;2-5 DO - 3.0.CO;2-5 ID - Haaften-Day2001 ER - TY - JOUR AU - Takagi, A. AU - Takeda, S. AU - Matsuoka, K. AU - Kinoshita, K. AU - Shimizu, K. PY - 1999 DA - 1999// TI - Macrophage colony – stimulating factor (M-CSF) production in vivo and in vitro in gynecologic malignancies JO - Int J Clin Oncol VL - 4 UR - https://doi.org/10.1007/s101470050044 DO - 10.1007/s101470050044 ID - Takagi1999 ER - TY - JOUR AU - Skates, S. AU - Horick, N. AU - Yu, Y. AU - Xu, F. J. AU - Berchuck, A. AU - Havrilesky, L. J. PY - 2004 DA - 2004// TI - Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA 125 II, CA 15–3, CA 72–4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.03.091 DO - 10.1200/JCO.2004.03.091 ID - Skates2004 ER - TY - JOUR AU - Zhang, Z. AU - Yu, Y. AU - Xu, F. X. AU - Berchuck, A. AU - Haaften-Day, C. AU - Havrilesky, L. J. PY - 2007 DA - 2007// TI - Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer JO - Gynecol Oncol VL - 107 UR - https://doi.org/10.1016/j.ygyno.2007.08.009 DO - 10.1016/j.ygyno.2007.08.009 ID - Zhang2007 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, E. AU - Gacuta- Szumarska, E. AU - Knapp, P. AU - Szmitowski, M. PY - 2008 DA - 2008// TI - The plasma levels and diagnostics utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients JO - Pol Merkur Lek VL - 145 ID - Ławicki2008 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, G. E. AU - Gacuta-Szumarska, E. AU - Szmitkowski, M. PY - 2012 DA - 2012// TI - Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients JO - Growth Factors VL - 30 UR - https://doi.org/10.3109/08977194.2011.627332 DO - 10.3109/08977194.2011.627332 ID - Ławicki2012 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, G. E. AU - Szmitkowski, M. PY - 2013 DA - 2013// TI - VEGF, M-CSF and CA 15–3 as a new tumor marker panel in breast malignancies: a multivariate analysis with ROC curve JO - Growth Factors VL - 31 UR - https://doi.org/10.3109/08977194.2013.797900 DO - 10.3109/08977194.2013.797900 ID - Ławicki2013 ER - TY - JOUR AU - Suzuki, M. AU - Kobajashi, H. AU - Ohwada, M. AU - Terao, T. AU - Sato, I. PY - 1998 DA - 1998// TI - Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary JO - Gynecol Oncol VL - 68 UR - https://doi.org/10.1006/gyno.1997.4897 DO - 10.1006/gyno.1997.4897 ID - Suzuki1998 ER - TY - JOUR AU - Xu, F. J. AU - Ramakrishnan, S. D. AU - Daly, L. AU - Soper, J. T. AU - Berchuk, A. AU - Clarke-Pearson, D. L. PY - 1991 DA - 1991// TI - Increased serum levels of macrophage colony-stimulating factor in ovarian cancer JO - Am J Obstet Gynecol VL - 165 UR - https://doi.org/10.1016/S0002-9378(12)90761-9 DO - 10.1016/S0002-9378(12)90761-9 ID - Xu1991 ER - TY - JOUR AU - Ghasemi, N. AU - Ghobadzadeh, S. AU - Zahraei, M. AU - Mohammadpour, H. AU - Bahrami, S. AU - Ganje, M. B. PY - 2014 DA - 2014// TI - HE4 combined with CA125: favorable screening tool for ovarian cancer JO - Med Oncol. VL - 31 UR - https://doi.org/10.1007/s12032-013-0808-0 DO - 10.1007/s12032-013-0808-0 ID - Ghasemi2014 ER - TY - JOUR AU - Molina, R. AU - Escudero, J. M. AU - Auge, J. M. AU - Filella, X. AU - Foj, L. AU - Torne, A. PY - 2011 DA - 2011// TI - HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases JO - Tumor Biol VL - 32 UR - https://doi.org/10.1007/s13277-011-0204-3 DO - 10.1007/s13277-011-0204-3 ID - Molina2011 ER - TY - JOUR AU - Yurkowetsky, Z. AU - Skates, S. AU - Lomakin, A. AU - Nolen, B. AU - Pulsipher, T. AU - Modugno, F. PY - 2010 DA - 2010// TI - Development of a multimarker assay for early detection of ovarian cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2008.19.2484 DO - 10.1200/JCO.2008.19.2484 ID - Yurkowetsky2010 ER - TY - JOUR AU - Kim, Y. M. AU - Whang, D. H. AU - Park, J. AU - Kim, S. H. AU - Lee, S. W. AU - Park, H. A. PY - 2011 DA - 2011// TI - Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case–control study in a Korean population JO - Clin Chem Lab Med VL - 49 ID - Kim2011 ER - TY - JOUR AU - Cooper, B. C. AU - Sood, A. K. AU - Davis, C. S. AU - Ritchie, J. M. AU - Sorosky, J. I. AU - Anderson, B. PY - 2002 DA - 2002// TI - Preoperative CA125 levels: an independent prognostic factor for epithelial ovarian cancer JO - Obstet Gynecol VL - 100 UR - https://doi.org/10.1016/S0029-7844(02)02057-4 DO - 10.1016/S0029-7844(02)02057-4 ID - Cooper2002 ER - TY - JOUR AU - Gadducci, A. AU - Ferdeghini, M. AU - Castellani, C. AU - Annicchiarico, C. AU - Prontera, C. AU - Facchini, V. PY - 1998 DA - 1998// TI - Serum macrophage colony stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer JO - Gynecol Oncol VL - 70 UR - https://doi.org/10.1006/gyno.1998.4259 DO - 10.1006/gyno.1998.4259 ID - Gadducci1998 ER - TY - JOUR AU - Burke, F. AU - Relf, M. AU - Negus, R. AU - Balkwill, F. PY - 1996 DA - 1996// TI - A cytokine profile of normal and malignant ovary JO - Cytokine VL - 8 UR - https://doi.org/10.1006/cyto.1996.0077 DO - 10.1006/cyto.1996.0077 ID - Burke1996 ER - TY - JOUR AU - Chudecka-Głaz, A. AU - Rzepka-Górska, I. AU - Wojciechowska, I. PY - 2012 DA - 2012// TI - Human epididymal protein 4 (HE4) is a novel biomarker and a promising prognostic factor in ovarian cancer patients JO - Eur J Gynaecol Oncol VL - 33 ID - Chudecka-Głaz2012 ER - TY - JOUR AU - Nolen, B. AU - Velikokhatnaya, L. AU - Marrangoni, A. AU - De Geest, K. AU - Lomakin, A. AU - Bast, R. C. PY - 2010 DA - 2010// TI - Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass JO - Gynecol Oncol VL - 117 UR - https://doi.org/10.1016/j.ygyno.2010.02.005 DO - 10.1016/j.ygyno.2010.02.005 ID - Nolen2010 ER - TY - JOUR AU - Ruggeri, G. AU - Bandiera, E. AU - Zanotti, L. AU - Belloni, S. AU - Ravaggi, A. AU - Romani, C. PY - 2011 DA - 2011// TI - HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm JO - Clin Chim Acta VL - 412 UR - https://doi.org/10.1016/j.cca.2011.04.028 DO - 10.1016/j.cca.2011.04.028 ID - Ruggeri2011 ER - TY - JOUR AU - Zheng, H. AU - Gao, Y. PY - 2012 DA - 2012// TI - Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease JO - Int J Gynecol Cancer VL - 22 UR - https://doi.org/10.1097/IGC.0b013e318249bee7 DO - 10.1097/IGC.0b013e318249bee7 ID - Zheng2012 ER - TY - JOUR AU - Kadija, S. AU - Stefanovic, A. AU - Jeremic, K. AU - Radojevic, M. M. AU - Nikolic, L. AU - Markovic, I. PY - 2012 DA - 2012// TI - The utility of human epididymal protein 4, cancer antigen 125, and risk of malignancy algorithm in ovarian cancer and endometriosis JO - Int J Gynecol Cancer VL - 22 UR - https://doi.org/10.1097/IGC.0b013e318234f852 DO - 10.1097/IGC.0b013e318234f852 ID - Kadija2012 ER - TY - JOUR AU - Park, Y. AU - Lee, J. -. H. AU - Hong, D. J. AU - Lee, E. Y. AU - Kim, H. -. S. PY - 2011 DA - 2011// TI - Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases JO - Clin Biochem VL - 44 UR - https://doi.org/10.1016/j.clinbiochem.2011.04.011 DO - 10.1016/j.clinbiochem.2011.04.011 ID - Park2011 ER - TY - JOUR AU - Gorelik, E. AU - Landsittel, D. P. AU - Marrangoni, A. M. AU - Modugno, F. AU - Veikokhatnaya, L. AU - Winans, M. T. PY - 2005 DA - 2005// TI - Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer JO - Cancer Epidemiol Biomark & Prev VL - 14 UR - https://doi.org/10.1158/1055-9965.EPI-04-0404 DO - 10.1158/1055-9965.EPI-04-0404 ID - Gorelik2005 ER - TY - JOUR AU - Nolen, B. AU - Marrangoni, A. AU - Velikokhatnaya, L. AU - Prosser, D. AU - Winans, M. AU - Gorelik, E. PY - 2009 DA - 2009// TI - A serum analysis of ovarian epithelial tumor genesis JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.09.043 DO - 10.1016/j.ygyno.2008.09.043 ID - Nolen2009 ER - TY - JOUR AU - Drapkin, R. AU - von Horsten, H. H. AU - Lin, Y. AU - Mok, S. C. AU - Crum, C. P. AU - Welch, W. R. PY - 2005 DA - 2005// TI - Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas JO - Cancer Res VL - 65 UR - https://doi.org/10.1158/0008-5472.CAN-04-3924 DO - 10.1158/0008-5472.CAN-04-3924 ID - Drapkin2005 ER - TY - JOUR AU - Macuks, R. AU - Baidekalna, I. AU - Donina, S. PY - 2012 DA - 2012// TI - An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions JO - Tumor Biol VL - 33 UR - https://doi.org/10.1007/s13277-012-0440-1 DO - 10.1007/s13277-012-0440-1 ID - Macuks2012 ER - TY - JOUR AU - Bodnar, L. AU - Wcisło, G. AU - Miedzińska-Maciejewska, M. AU - Szczylik, C. PY - 2003 DA - 2003// TI - The role of macrophage colony-stimulating factor (M-CSF) in prognosis, diagnosis and in the treatment of epithelial ovarian cancer JO - Wspol Onkol VL - 7 ID - Bodnar2003 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, G. E. AU - Gacuta-Szumarska, E. AU - Czygier, M. AU - Szmitkowski, M. PY - 2010 DA - 2010// TI - The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri JO - Pol Merkur Lek VL - 167 ID - Ławicki2010 ER - TY - JOUR AU - Ławicki, S. AU - Będkowska, G. E. AU - Gacuta-Szumarska, E. AU - Szmitkowski, M. PY - 2013 DA - 2013// TI - The plasma concentration of VEGF, HE4 and CA125 as a new biomarkers panel in different stages and sub-types of epithelial ovarian tumors JO - J Ovarian Res VL - 6 UR - https://doi.org/10.1186/1757-2215-6-45 DO - 10.1186/1757-2215-6-45 ID - Ławicki2013 ER - TY - JOUR AU - Holcomb, K. AU - Vucetic, Z. AU - Miller, M. C. AU - Knapp, R. C. PY - 2011 DA - 2011// TI - Human epididymis protein 4 offers superior specificity in the differentiation of benign and malignant adnexal masses in premenopausal women JO - Am J Obstet Gynecol VL - 205 UR - https://doi.org/10.1016/j.ajog.2011.05.017 DO - 10.1016/j.ajog.2011.05.017 ID - Holcomb2011 ER - TY - JOUR AU - Chan, K. K. L. AU - Chen, C. A. AU - Nam, J. H. AU - Ochiai, K. AU - Wilailak, S. AU - Choon, A. T. PY - 2013 DA - 2013// TI - The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass JO - Gynecol Oncol VL - 128 UR - https://doi.org/10.1016/j.ygyno.2012.09.034 DO - 10.1016/j.ygyno.2012.09.034 ID - Chan2013 ER - TY - JOUR AU - Sandri, M. T. AU - Bottari, F. AU - Franchi, D. AU - Boveri, S. AU - Candiani, M. AU - Ronzoni, S. PY - 2013 DA - 2013// TI - Comparison of HE4, CA 125 and ROMA algorithm in women with a pelvic mass: correlation with pathological outcome JO - Gynecol Oncol VL - 128 UR - https://doi.org/10.1016/j.ygyno.2012.11.026 DO - 10.1016/j.ygyno.2012.11.026 ID - Sandri2013 ER -